Skip to Content

4D Molecular Therapeutics Inc Ordinary Shares FDMT

Morningstar Rating
$25.25 +0.47 (1.90%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FDMT is trading at a 51% discount.
Price
$24.70
Fair Value
$75.46
Uncertainty
Extreme
1-Star Price
$816.13
5-Star Price
$7.64
Economic Moat
Vzjjx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FDMT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$24.78
Day Range
$24.3825.56
52-Week Range
$9.4436.25
Bid/Ask
$22.22 / $25.40
Market Cap
$1.29 Bil
Volume/Avg
635,044 / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
47.73
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
147

Comparables

Valuation

Metric
FDMT
SWTX
KPTI
Price/Earnings (Normalized)
Price/Book Value
3.544.71
Price/Sales
47.73464.711.00
Price/Cash Flow
Price/Earnings
FDMT
SWTX
KPTI

Financial Strength

Metric
FDMT
SWTX
KPTI
Quick Ratio
15.216.213.14
Current Ratio
15.656.413.37
Interest Coverage
−5.45
Quick Ratio
FDMT
SWTX
KPTI

Profitability

Metric
FDMT
SWTX
KPTI
Return on Assets (Normalized)
−25.94%−39.61%−42.20%
Return on Equity (Normalized)
−28.64%−45.43%
Return on Invested Capital (Normalized)
−31.25%−49.28%−111.18%
Return on Assets
FDMT
SWTX
KPTI
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRLhynphnqmhHxxb$550.4 Bil
VRTX
Vertex Pharmaceuticals IncRhgtvjhjpTlyjf$101.7 Bil
REGN
Regeneron Pharmaceuticals IncCxrnjgvGrknmd$98.1 Bil
MRNA
Moderna IncDlcphwmdJrsq$38.8 Bil
ARGX
argenx SE ADRPkvywqxjTkp$21.7 Bil
BNTX
BioNTech SE ADRTtyzvvdpNgjc$20.8 Bil
ALNY
Alnylam Pharmaceuticals IncQdjpvgmgZytjnt$18.4 Bil
BMRN
Biomarin Pharmaceutical IncTdwhhmhbSgvdd$17.1 Bil
RPRX
Royalty Pharma PLC Class APyyhqwlgkfSyztpw$12.5 Bil
INCY
Incyte CorpYgcscjcrgFnpgjr$11.9 Bil

Sponsor Center